Susquehanna International Group, LLP Maia Biotechnology, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 55,100 shares of MAIA stock, worth $92,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,100
Previous 11,649
373.0%
Holding current value
$92,017
Previous $22,000
281.82%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
1.23MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA650KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$358,1090.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$131,1300.0% of portfolio
-
Centric Wealth Management68.2KShares$113,9740.03% of portfolio
-
State Street Corp Boston, MA53.3KShares$88,9270.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.3M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...